FOXP3 and breast cancer: CD8+ T cells was reported to be associated with the outcome of breast cancer [21], Foxp3+ regulatory T cells (Treg cells) was significantly associated with poor survival of majority of solid tumors, including cervical, renal, melanomas, and breast cancers [22].